mTOR Pathway Substrates Present High Activation in Vascular Malformations and Significantly Decrease with Age.
Jakub KopećElżbieta Sałacińska-ŁośMagdalena Julita OrzechowskaMonika SokolnickaAleksandra Gawłowska-MarciniakPrzewratil PrzemysławPublished in: Diagnostics (Basel, Switzerland) (2023)
The higher expression of mTOR substrates in vascular malformations compared to healthy tissue confirms their involvement in abnormal vascular development. Age-related changes in mTOR substrate expression highlight the need for timely intervention. Our study contributes to the understanding of the mTOR signaling pathway in vascular malformations and highlights its potential as a therapeutic target, contributing to personalized medicine.